OIG Findings on Medicare Advantage Denials of Nursing Home Care Renew Calls for ‘Meaningful Penalties’

Why It Matters

Improper denials delay critical post‑acute care, increase hospital stays, and raise costs for seniors and providers, highlighting a systemic oversight gap in Medicare Advantage. Meaningful penalties could force insurers to tighten prior‑authorization processes and protect vulnerable patients.

Key Takeaways

• Medicare Advantage denied 12% of nursing home admission requests.
• 95% of appealed denials were reversed, yet only 18% were appealed.
• Long‑stay residents faced a 40% denial rate versus 11% for others.
• Contractor naviHealth denied 14% of requests, higher than internal reviews.
• OIG urges CMS to impose meaningful penalties on Medicare Advantage plans.

Pulse Analysis

The OIG’s latest investigation shines a light on a troubling pattern within Medicare Advantage: a sizable share of nursing‑home admission requests are being blocked at the prior‑authorization stage, only to be approved after a cumbersome appeal. With 13,500 denials out of 109,400 requests examined, the data reveal a systemic reliance on gatekeeping that may not be medically justified. The stark contrast between the 12% overall denial rate and the 95% reversal rate on appeal underscores a potential misalignment between insurer protocols and patient needs, especially when merely 18% of beneficiaries pursue an appeal.

For patients, the impact is immediate and severe. Delays of six to ten days between the initial request and final decision can extend hospital stays, inflate costs, and jeopardize recovery for seniors recovering from surgery or acute illness. The burden falls disproportionately on long‑stay nursing‑home residents, who encounter a 40% denial rate—four times higher than other enrollees. Contractors such as UnitedHealth’s naviHealth, responsible for half of the reviewed authorizations, exhibited a higher denial rate (14%) than internal reviews, raising questions about training, oversight, and potential financial incentives to favor lower‑cost alternatives like home health services.

Policy makers and industry leaders are now faced with a clear mandate: strengthen enforcement mechanisms. The OIG recommends that CMS investigate the high overturn rate, the wide variance among plans, and the elevated denials for nursing‑home residents. Without meaningful penalties, insurers may continue to treat compliance issues as a cost of doing business. Robust oversight could align prior‑authorization practices with clinical necessity, reduce unnecessary delays, and ultimately safeguard the health outcomes and financial stability of both beneficiaries and skilled‑nursing facilities.